Improved labelling of no-carrier-added 123i-mibg and preliminary clinical evaluation in patients with ventricular arrhythmias

Nuclear Medicine Communications

Volumn 20, Issue 6, 1999, Pages 537-545

  Samnick, S ^a   Bader, J B ^a   MaLler M ^a   Chapot, C ^a   Richter, S ^a   Schaefer, A ^a   Sax, B ^a   Kirsch, C M ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; POTASSIUM PERCHLORATE; TECHNETIUM 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEBROMINATION; DRUG STABILITY; DRUG UPTAKE; FEMALE; HEART VENTRICLE ARRHYTHMIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PHEOCHROMOCYTOMA; PHOTON EMISSION TOMOGRAPHY; SYMPATHETIC INNERVATION;

3-IODOBENZYLGUANIDINE; AGED; ARRHYTHMIA; EVALUATION STUDIES; FEMALE; HUMANS; IODINE RADIOISOTOPES; LIVER; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032757762     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199906000-00008     Document Type: Article

References (23)

1. Beierwaltes WH. Uptake on basic research and clinical experience with meta-iodobenzyl-guanidine. Med Fed Oncol 1987; 15: 163-167.
2. Troncone L, Rufini V, Montemaggi P, Danza FM, Lasorella A, Mastrangelo R. The diagnostic and therapeutic utility of radioiodinated meta-iodobenzylguanidine (MIBG): 5 years experience. Eur J Nucl Med 1990; 16: 325-331.
3. Sisson JC, Wieland DM, Sherman P, Mangner TJ, Tobes MC, Jacques S Jr. Meta-iodo-benzylguanindine as an index of the adrenergic nervous system integrity and function. J Nucl Med 1987; 28: 1620-1624.
4. Schaefers M, Schober O, Lerch H. Cardiac sympathetic neurotransmission scintigraphy. Eur J Nucl Med 1998; 25: 435-441.
5. Münch G, Ziegler S, Nguyen N, Hartmann F, Watzlowik P, Schwaiger M. Scintigraphic evaluation of cardiac autonomic innervation. J Nucl Cardiol 1996; 3: 265-277.
6. Giordano A, Calcagni ML, Rossi Brunella et al. Potential use of iodine-123 metaiodobenzylguanidine radioaerosol as a marker of pulmonary neuroadrenergic function. Eur J Nucl Med 1997; 24: 52-58.
7. Vaidyanathan G, Zalutsky MR. No-carrier-added metaiodobenzylguanidine: Synthesis and preliminary evaluation. Nucl Med Biol 1995; 22: 61-64.
8. Mock BH, Tuli MM. Influence of specific activity on myocardial uptake of 1231-mIBG in rats. Nucl Med Commun 1988; 9: 663-667.
9. Mairs RJ, Cunningham SH, Russell J et al. No-carrier-added iodine-131-MIBG: Evaluation of a therapeutic preparation. J Nucl Med 1995; 36: 1088-1095.
10. Farahati J, Coenen HH, Dutschka K et al. Effect of specific activity on neuroblastoma uptake of I-123-meta-iodobenzylguanidine in nude mice xenografted with SK-N-SK cells. Oncol Reports 1997; 4: 363-366.
11. Farahati J, Bier D, Scheubeck M et al. Effect of specific activity on cardiac uptake of iodine-123-MIBG. J Nucl Med 1997; 38: 447-451.
12. 99mTc-MIBI SPECT in patients scheduled for implantation of an intra cardiac defibrilator (ICD). Eur J Nucl Med 1997; 24: 998.
13. 131I]Iodobenzyl-guanidine. J Nucl Med 1980; 21: 349-353.
14. Bier D, Dutschka K, Brandau W, Reiners C. Einfache Synthese von Phenylfettsäure-Tributyl-zinnverbindungen für schnelle Radioiodierungen mit hohen Markierungsausbeuten am Beispiel der PHIPA 3-10. Nuklearmedizin 1998; 37: A53.
15. 131I-meta-iodobenzylguanidine: Comparison of production from meta-diazobenzylguanidine and from meta-trimethyl-silylbenzylguanidine. Nucl Med Commun 1994; 15: 268-274.
16. 2 receptor agent. Nucl Med Biol 1997; 24: 295-303.
17. Moerlein SM. Regiospecific aromatic radioiodination via no-carrier-added copper(I)chloride assisted iododebrom-ination. Radiochim Acta 1990; 50: 55-61.
18. 125I-labelled β-CIT and its co-fluoroalkyl analogues β-CIT-FE and β-CIT-FP, including synthesis of precursors. J Labd Compd Radiopharm 1996; 38: 676-685.
19. Mozley PD, Stubbs JB, Kim HJ et al. Dosimetry of an iodine-123-labeled tropane to image dopamine transporters. J Nucl Med 1996; 37: 151-159.
20. Carrió I., Highlights of the annual meeting of the European Association of Nuclear Medicine: Glasgow 1997. The Flowering of Science and Art of Nuclear Medicine in Europe. Eur J Nucl Med 1997; 24: 1527-1540.
21. Murashima S, Tekeda K, Matsumura K et al. Increased lung uptake of iodine-123-MIBG in diabetics with sympathetic nervous dysfunction. J Nucl Med 1998; 39: 334-338.
22. Mangner TJ, Tobes MC, Wieland DM, Sisson JC, Shapiro B. Metabolism of iodine-131 meta-iodobenzylguanidine in patients with metastatic pheochromocytoma. J Nucl Med 1986; 27: 37-44.
23. 131I]MIBG uptake in pheochromocytoma. Eur J Nucl Med 1998; 25: 1132.